Microsoft has confirmed that the September 2025 security updates are causing Active Directory issues on Windows Server 2025 systems. As the company explains in a Windows release health dashboard ...

Microsoft has reminded that Exchange Server 2016 and 2019 reached the end of support and advised IT administrators to upgrade servers to Exchange Server SE or migrate to Exchange Online. According to ...

To give its users more time to upgrade their software and hardware to Windows 11, Microsoft has promised to continue supporting Windows 10 with one more year of security updates. Anyone with Windows ...

Microsoft says the ESU program is "not intended as a long-term solution but rather as a temporary bridge to stay secure while one migrates to a newer, supported platform."  Windows security ...

Microsoft’s October Patch Tuesday releases will fix 167 vulnerabilities, the highest number this year, including seven rated as critical that need immediate attention from CISOs. Separately, SAP ...

Proton VPN stands out for two main reasons: it's one of the only virtual private networks (VPNs) to include a free plan with no data limits, and it's one of the few services majority-owned by a ...

Microsoft is removing known workarounds for local account creation in Windows 11 setup (OOBE), effectively making a Microsoft Account (MSA) mandatory for most users. The company cites proper ...

The SER9 Pro is another all-round excellent mini PC from Beelink, now powered by an AMD Ryzen 7 H 255. The CPU is good, though it is more or less a rebadged Ryzen XXX. The GPU is a very good for an ...

If you're not willing or able to pay for the costs of some of the best Windows laptops, your best bet is to turn to budget-friendly laptops that are designed to offer users a decent computing ...

Best practices include a focus on hardening user authentication and access, ensuring strong network encryption, and minimizing application attack surfaces.

During the 6-year period, 199 new indications for solid tumors were approved by the FDA; 138 (69.3%) were also approved by EMA and 124 (62.3%) by ANVISA. Discrepancies between approved labels and the ...